Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2026-02-03 @ 9:59 AM
Study NCT ID:
NCT04088032
Status:
WITHDRAWN
Last Update Posted:
2020-07-16
First Post:
2019-09-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer
Sponsor:
Alison Stopeck
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-10
First Submit QC Date:
None
Study First Post Date:
2019-09-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-14
Last Update Post Date:
2020-07-16
Last Update Post Date Type:
ACTUAL